2016 Global Survey on Clinical Next-Generation Sequencing

2016 Global Survey on Clinical Next-Generation Sequencing

Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications

RELEASE DATE
09-Jan-2017
REGION
North America
Research Code: 9AB9-00-5E-00-00
SKU: HC02711-NA-CR_19328
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC02711-NA-CR_19328
$4,950.00
DownloadLink
ENQUIRE NOW

Description

The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications. The survey seeks to collect the following key information:

•     Outsourcing needs and clinical NGS service providers
•     Current and future interest areas of clinical NGS
•     Genetic elements of interest
•     Purchase patterns for instruments and reagents
•     Predominantly used clinical methods (e.g., chip sequencing, whole exome)
•     Perspectives of NGS used as complement or replacement for current methods
•     Platforms used for NGS clinical data interpretation
•     Predominantly cited instruments for clinical use
•     Familiarity with clinical NGS service providers
•     Factors promoting adoption
•     Factors limiting adoption
•     Best practices from labs—direct quotes from lab managers

Research Methodology
Lab managers of clinical labs were invited to participate in an online survey during August–November 2016. To qualify for survey participation, respondents had to be working in a private or public laboratory, clinical research institution, reference laboratory, academic medical center facility, hospital lab, or diagnostic company that employs NGS for clinical use. Respondents had to be constant users of this technology, belong to the scientific community, and be in a position to authorize purchases. Over 184 respondents qualified for the survey including C-level officers, lab managers, directors, physicians, post docs, and principal investigators that had a direct interference with the clinical NGS community. End users were also evaluated for their ability to authorize purchases or make product recommendations. Respondents indicated a wide range of job titles, such as lab directors, scientists, lab managers, clinicians, pathologists, and lab technicians. In total, about 82% of respondents work in the United States. Nevertheless, this study is considered global because the survey was open to respondents from all countries.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Research Objectives

Research Methodology

Research Methodology (continued)

Technology Usage and Outsourced Respondents

Respondent Demographics

Respondent Demographics (continued)

Brand Perception of Top 16 Providers

Current and Future Interest Areas for Clinical NGS Testing

Top 7 Preferred Vendors for NGS Clinical Sequencing Services

Areas of Pathogen Clinical Research and Methodology Used

Interest in Pursuing NGS-based Infectious Disease Testing

Current and Future Plans in Infectious Disease Testing

Brand Familiarity for Infectious Disease Testing

Sequencing Methods Used for Testing

Infectious Disease Sequencing Method

Genetic Elements of Interest for NGS Clinical Work

Correlation of Genetic Elements and Clinical Area of Interest

Correlation of Genetic Elements and Sequencing Methods

Instrument and Reagent Purchase Patterns

Instrument and Reagent Purchase Patterns (continued)

Complemented or Replaced Instruments in Labs

Complementing Instruments/Methods

Instrument Usage—Current and Future Use for Clinical Applications

Analysis of Instruments and Clinical Applications

NGS Data Analysis

Data Analysis for Specific Infectious Disease NGS Application

Current and Future Usage of NGS Informatics Platforms

Factors Promoting Adoption of Clinical NGS

Factors Limiting the Adoption of Clinical NGS

Factors that Helped Overcome Obstacles to Implementing NGS

Legal Disclaimer

Additional Sources of Information

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

North America and Europe Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications. The survey seeks to collect the following key information: • Outsourcing needs and clinical NGS service providers • Current and future interest areas of clinical NGS • Genetic elements of interest • Purchase patterns for instruments and reagents • Predominantly used clinical methods (e.g., chip sequencing, whole exome) • Perspectives of NGS used as complement or replacement for current methods • Platforms used for NGS clinical data interpretation • Predominantly cited instruments for clinical use • Familiarity with clinical NGS service providers • Factors promoting adoption • Factors limiting adoption • Best practices from labs—direct quotes from lab managers Research Methodology Lab managers of clinical labs were invited to participate in an online survey during August–November 2016. To qualify for survey participation, respondents had to be working in a private or public laboratory, clinical research institution, reference laboratory, academic medical center facility, hospital lab, or diagnostic company that employs NGS for clinical use. Respondents had to be constant users of this technology, belong to the scientific community, and be in a position to authorize purchases. Over 184 respondents qualified for the survey including C-level officers, lab managers, directors, physicians, post docs, and principal investigators that had a direct interference with the clinical NGS community. End users were also evaluated for their ability to authorize purchases or make product recommendations. Respondents indicated a wide range of job titles, such as lab directors, scientists, lab managers, clinicians, pathologists, and lab technicians. In total, about 82% of respondents work in the United States. Nevertheless, this study is considered global because the survey was open to respondents from all countries.
More Information
No Index No
Podcast No
Author Divyaa Ravishankar
Industries Healthcare
WIP Number 9AB9-00-5E-00-00
Is Prebook No